A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Clinical trial NCT07011056 · RECRUITING
Trial details
- NCT number
- NCT07011056
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2029-06-30
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.